Paper39201338
Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads.
Tonon G and 3 others. Int J Mol Sci, 2024. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads. Papers, record 39201338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201338
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Immunoconjugates | Major topic |
| Humans | |
| Antineoplastic Agents | |
| Animals | |
| Antibodies, Monoclonal |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| IG23566 | AIRC | PubMed |
Source PubMed
References203
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22881720 | Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy. | Bioconjug Chem | 2012 | https://conductscience.org/library/papers/22881720 | PubMed |
| 2 | 31011424 | Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma. | Biomark Res | 2019 | https://conductscience.org/library/papers/31011424 | PubMed |
| 3 | 38555326 | Transforming toxins into treatments: the revolutionary role of α-amanitin in cancer therapy. | Arch Toxicol | 2024 | https://conductscience.org/library/papers/38555326 | PubMed |
| 4 | 35285835 | Photoactivatable bis(thiosemicarbazone) derivatives for copper-64 radiotracer synthesis. | Dalton Trans | 2022 | https://conductscience.org/library/papers/35285835 | PubMed |
| 5 | 32402935 | Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/32402935 | PubMed |
| 6 | 32698317 | Monoclonal Antibodies in Cancer Therapy. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/32698317 | PubMed |
| 7 | 28613309 | A simple synthetic entryway into palladium cross-coupling catalysis. | Chem Commun (Camb) | 2017 | https://conductscience.org/library/papers/28613309 | PubMed |
| 8 | 21457108 | The development of pyrrolobenzodiazepines as antitumour agents. | Expert Opin Investig Drugs | 2011 | https://conductscience.org/library/papers/21457108 | PubMed |
| 9 | 10565792 | Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia. | J Nucl Med | 1999 | https://conductscience.org/library/papers/10565792 | PubMed |
| 10 | 33926914 | First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33926914 | PubMed |
| 11 | 10755652 | Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb. | Nucl Med Biol | 2000 | https://conductscience.org/library/papers/10755652 | PubMed |
| 12 | 33845034 | Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/33845034 | PubMed |
| 13 | 30095185 | Bioconjugation with Maleimides: A Useful Tool for Chemical Biology. | Chemistry | 2019 | https://conductscience.org/library/papers/30095185 | PubMed |
| 14 | 8324745 | Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics. | Cancer Res | 1993 | https://conductscience.org/library/papers/8324745 | PubMed |
| 15 | 30478951 | Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30478951 | PubMed |
| 16 | 35770072 | Heptadentate chelates for 89Zr-radiolabelling of monoclonal antibodies. | Inorg Chem Front | 2022 | https://conductscience.org/library/papers/35770072 | PubMed |
| 17 | 7850803 | Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates. | Cancer Res | 1995 | https://conductscience.org/library/papers/7850803 | PubMed |
| 18 | 37146495 | Analytical methods for amatoxins: A comprehensive review. | J Pharm Biomed Anal | 2023 | https://conductscience.org/library/papers/37146495 | PubMed |
| 19 | 33461955 | Efficacy and Safety of Inotuzumab Ozogamicin (CMC-544) for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis. | Clin Lymphoma Myeloma Leuk | 2021 | https://conductscience.org/library/papers/33461955 | PubMed |
| 20 | 2353935 | Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. | Biochem Pharmacol | 1990 | https://conductscience.org/library/papers/2353935 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42633296 | Metal coordination at biological interfaces: Mechanisms, therapeutics, and translation. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42633296 | PubMed |
| 42389487 | Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42389487 | PubMed |
| 42168552 | Metabolotheranostics of pancreatic cancer by targeting choline, glutamine, and glucose transporters with photoimmunotherapy. | Npj Imaging | 2026 | https://conductscience.org/library/papers/42168552 | PubMed |
| 42099878 | Antibody-drug conjugates in cancer treatment: from molecular design to clinical implementation. | Lancet Reg Health Eur | 2026 | https://conductscience.org/library/papers/42099878 | PubMed |
| 42079870 | Antibody-drug conjugates for infectious and neglected tropical diseases: chemical design principles, target biology, and translational challenges. | Front Chem | 2026 | https://conductscience.org/library/papers/42079870 | PubMed |
| 41789080 | Clinical applications of antibody-drug conjugates in advanced non-small cell lung cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789080 | PubMed |
| 41311216 | Antibody-oligonucleotide conjugates for spatial proteomics: principles, applications, and challenges. | Acta Biochim Biophys Sin (Shanghai) | 2025 | https://conductscience.org/library/papers/41311216 | PubMed |
| 41304752 | Camptothecin in Cancer Therapy: Current Challenges and Emerging Strategies with Nanoemulsions. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41304752 | PubMed |
| 40827507 | Evolving bioanalytical strategies in the wake of pioneering biotherapeutics. | Bioanalysis | 2025 | https://conductscience.org/library/papers/40827507 | PubMed |
| 40129921 | Antibody conjugates in neuroblastoma: a step forward in precision medicine. | Front Oncol | 2025 | https://conductscience.org/library/papers/40129921 | PubMed |
| 40075649 | Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075649 | PubMed |
| 39769122 | Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough? | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769122 | PubMed |
| 39582282 | Assessing the expression of Nectin-4 in solid tumors by immunohistochemistry - what do we know? | Histol Histopathol | 2025 | https://conductscience.org/library/papers/39582282 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201338
GET https://conductscience.org/api/papers/v1/39201338/references?page=2